339 related articles for article (PubMed ID: 33688910)
21. Severity and Area Score for Hidradenitis (SASH): a novel outcome measurement for hidradenitis suppurativa.
Kirby JS; Butt M; King T
Br J Dermatol; 2020 Apr; 182(4):940-948. PubMed ID: 31233623
[TBL] [Abstract][Full Text] [Related]
22. Reliability of the hidradenitis suppurativa clinical response in the assessment of patients with hidradenitis suppurativa.
Kimball AB; Ganguli A; Fleischer A
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2254-2256. PubMed ID: 29959796
[TBL] [Abstract][Full Text] [Related]
23. Guidance on COVID-19 Vaccination in Hidradenitis Suppurativa Patients: A Modified Delphi Consensus of Experts.
Rick JW; De DR; Shih T; Alavi A; Kirby JS; Naik HB; Frew JW; Sayed CJ; Hsiao JL; Shi VY
Skin Appendage Disord; 2022 Jul; 8(4):287-290. PubMed ID: 35979524
[TBL] [Abstract][Full Text] [Related]
24. Establishing consensus among community clinicians on how to categorize and define preschoolers' speech and language impairments at assessment.
Cunningham BJ; Kwok E; Turkstra L; Oram Cardy J
J Commun Disord; 2019; 82():105925. PubMed ID: 31434024
[TBL] [Abstract][Full Text] [Related]
25. International consensus on clinical severity scale use in evaluating Niemann-Pick disease Type C in paediatric and adult patients: results from a Delphi Study.
Evans W; Patterson M; Platt F; Guldberg C; Mathieson T; Pacey J;
Orphanet J Rare Dis; 2021 Nov; 16(1):482. PubMed ID: 34794481
[TBL] [Abstract][Full Text] [Related]
26. Expert consensus document: Semantics in active surveillance for men with localized prostate cancer - results of a modified Delphi consensus procedure.
Bruinsma SM; Roobol MJ; Carroll PR; Klotz L; Pickles T; Moore CM; Gnanapragasam VJ; Villers A; Rannikko A; Valdagni R; Frydenberg M; Kakehi Y; Filson CP; Bangma CH;
Nat Rev Urol; 2017 May; 14(5):312-322. PubMed ID: 28290462
[TBL] [Abstract][Full Text] [Related]
27. Consensus on revised definitions of Morphological Uterus Sonographic Assessment (MUSA) features of adenomyosis: results of modified Delphi procedure.
Harmsen MJ; Van den Bosch T; de Leeuw RA; Dueholm M; Exacoustos C; Valentin L; Hehenkamp WJK; Groenman F; De Bruyn C; Rasmussen C; Lazzeri L; Jokubkiene L; Jurkovic D; Naftalin J; Tellum T; Bourne T; Timmerman D; Huirne JAF
Ultrasound Obstet Gynecol; 2022 Jul; 60(1):118-131. PubMed ID: 34587658
[TBL] [Abstract][Full Text] [Related]
28. Key terms and definitions in acute porphyrias: Results of an international Delphi consensus led by the European porphyria network.
Stein PE; Edel Y; Mansour R; Mustafa RA; Sandberg S;
J Inherit Metab Dis; 2023 Jul; 46(4):662-674. PubMed ID: 37067064
[TBL] [Abstract][Full Text] [Related]
29. Validation of the Hidradenitis Suppurativa Investigator Global Assessment: A Novel Hidradenitis Suppurativa-Specific Investigator Global Assessment for Use in Interventional Trials.
Garg A; Zema C; Ciaravino V; Rolleri R; Peterson L; Garcia L; Massaro T; Jemec GBE; Kirby JS; Thorlacius L; Ingram JR
JAMA Dermatol; 2023 Jun; 159(6):606-612. PubMed ID: 37099284
[TBL] [Abstract][Full Text] [Related]
30. Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group.
Zouboulis CC; Bechara FG; Dickinson-Blok JL; Gulliver W; Horváth B; Hughes R; Kimball AB; Kirby B; Martorell A; Podda M; Prens EP; Ring HC; Tzellos T; van der Zee HH; van Straalen KR; Vossen ARJV; Jemec GBE
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):19-31. PubMed ID: 30176066
[TBL] [Abstract][Full Text] [Related]
31. A narrative review of the definition of 'flare' in hidradenitis suppurativa.
Kirby JS; Moore B; Leiphart P; Shumaker K; Mammis-Gierbolini A; Benhadou F; Del Marmol V
Br J Dermatol; 2020 Jan; 182(1):24-28. PubMed ID: 31025310
[TBL] [Abstract][Full Text] [Related]
32. Establishing a consensus on wound infection definitions.
Haesler E; Swanson T; Ousey K; Larsen D; Carville K; Bjarnsholt T; Haesler P
J Wound Care; 2022 Dec; 31(Sup12):S48-S59. PubMed ID: 36475847
[TBL] [Abstract][Full Text] [Related]
33. Development and initial validation of the HS-IGA: a novel hidradenitis suppurativa-specific investigator global assessment for use in interventional trials.
Garg A; Zema C; Kim K; Gao W; Chen N; Jemec GBE; Kirby J; Thorlacius L; Villumsen B; Ingram JR
Br J Dermatol; 2022 Aug; 187(2):203-210. PubMed ID: 35599448
[TBL] [Abstract][Full Text] [Related]
34. Towards global consensus on core outcomes for hidradenitis suppurativa research: an update from the HISTORIC consensus meetings I and II.
Thorlacius L; Garg A; Ingram JR; Villumsen B; Theut Riis P; Gottlieb AB; Merola JF; Dellavalle R; Ardon C; Baba R; Bechara FG; Cohen AD; Daham N; Davis M; Emtestam L; Fernández-Peñas P; Filippelli M; Gibbons A; Grant T; Guilbault S; Gulliver S; Harris C; Harvent C; Houston K; Kirby JS; Matusiak L; Mehdizadeh A; Mojica T; Okun M; Orgill D; Pallack L; Parks-Miller A; Prens EP; Randell S; Rogers C; Rosen CF; Choon SE; van der Zee HH; Christensen R; Jemec GBE
Br J Dermatol; 2018 Mar; 178(3):715-721. PubMed ID: 29080368
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa: A Phase 2, Double-blind, Placebo-Controlled Randomized Clinical Trial.
Glatt S; Jemec GBE; Forman S; Sayed C; Schmieder G; Weisman J; Rolleri R; Seegobin S; Baeten D; Ionescu L; Zouboulis CC; Shaw S
JAMA Dermatol; 2021 Nov; 157(11):1279-1288. PubMed ID: 34406364
[TBL] [Abstract][Full Text] [Related]
36. Definitions for Loss of Domain: An International Delphi Consensus of Expert Surgeons.
Parker SG; Halligan S; Liang MK; Muysoms FE; Adrales GL; Boutall A; de Beaux AC; Dietz UA; Divino CM; Hawn MT; Heniford TB; Hong JP; Ibrahim N; Itani KMF; Jorgensen LN; Montgomery A; Morales-Conde S; Renard Y; Sanders DL; Smart NJ; Torkington JJ; Windsor ACJ
World J Surg; 2020 Apr; 44(4):1070-1078. PubMed ID: 31848677
[TBL] [Abstract][Full Text] [Related]
37. International Consensus for ultrasound lesions in gout: results of Delphi process and web-reliability exercise.
Gutierrez M; Schmidt WA; Thiele RG; Keen HI; Kaeley GS; Naredo E; Iagnocco A; Bruyn GA; Balint PV; Filippucci E; Mandl P; Kane D; Pineda C; Delle Sedie A; Hammer HB; Christensen R; D'Agostino MA; Terslev L;
Rheumatology (Oxford); 2015 Oct; 54(10):1797-805. PubMed ID: 25972391
[TBL] [Abstract][Full Text] [Related]
38. Physical Restraints: Consensus of a Research Definition Using a Modified Delphi Technique.
Bleijlevens MH; Wagner LM; Capezuti E; Hamers JP;
J Am Geriatr Soc; 2016 Nov; 64(11):2307-2310. PubMed ID: 27640335
[TBL] [Abstract][Full Text] [Related]
39. Guideline on terminology and definitions of updating clinical guidelines: The Updating Glossary.
Martínez García L; Pardo-Hernández H; Sanabria AJ; Alonso-Coello P; Penman K; McFarlane E;
J Clin Epidemiol; 2018 Mar; 95():28-33. PubMed ID: 29208415
[TBL] [Abstract][Full Text] [Related]
40. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
